|  Help  |  About  |  Contact Us

Publication : Sequencing two Tyr::CreER<sup>T2</sup> transgenic mouse lines.

First Author  Aktary Z Year  2019
Journal  Pigment Cell Melanoma Res PubMed ID  31679174
Mgi Jnum  J:282623 Mgi Id  MGI:6383321
Doi  10.1111/pcmr.12842 Citation  Aktary Z, et al. (2019) Sequencing two Tyr::CreER(T2) transgenic mouse lines. Pigment Cell Melanoma Res
abstractText  The Cre/loxP system is a powerful tool that has allowed the study of the effects of specific genes of interest in various biological settings. The Tyr::CreER(T2) system allows for the targeted expression and activity of the Cre enzyme in the melanocyte lineage following treatment with tamoxifen, thus providing spatial and temporal control of the expression of specific target genes. Two independent transgenic mouse models, each containing a Tyr::CreER(T2) transgene, have been generated and are widely used to study melanocyte transformation. In this study, we performed whole genome sequencing (WGS) on genomic DNA from the two Tyr::CreER(T2) mouse models and identified their sites of integration in the C57BL/6 genome. Based on these results, we designed PCR primers to accurately, and efficiently, genotype transgenic mice. Finally, we discussed some of the advantages of each transgenic mouse model.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression